{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T04:52:54Z","timestamp":1794718374018,"version":"4.9.1"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T00:00:00Z","timestamp":1686700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T00:00:00Z","timestamp":1686700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81902426"],"award-info":[{"award-number":["81902426"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012151","name":"Sanming Project of Medicine in Shenzhen","doi-asserted-by":"publisher","award":["SZSM201911010"],"award-info":[{"award-number":["SZSM201911010"]}],"id":[{"id":"10.13039\/501100012151","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Guangdong-Hong Kong-Macau University Joint Laboratory of Digestive Cancer Research","award":["2021LSYS003"],"award-info":[{"award-number":["2021LSYS003"]}]},{"name":"Guangdong Provincial Key Laboratory of Digestive Cancer Research","award":["2021B1212040006"],"award-info":[{"award-number":["2021B1212040006"]}]},{"DOI":"10.13039\/501100013093","name":"Science and Technology Planning Project of Shenzhen Municipality","doi-asserted-by":"crossref","award":["JCYJ20210324122612032"],"award-info":[{"award-number":["JCYJ20210324122612032"]}],"id":[{"id":"10.13039\/501100013093","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Shenzhen Key Laboratory of Chinese Medicine Active substance screening and Translational Research","award":["ZDSYS20220606100801003"],"award-info":[{"award-number":["ZDSYS20220606100801003"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Clinical hyperthermic intraperitoneal chemotherapy (HIPEC) is regarded as a potential treatment that can prolong survival of patients with peritoneal metastases after cytoreductive surgery. However, treated tumor cells are prone to becoming heat resistant to HIPEC therapy through high expression of heat shock proteins (HSPs). Here, a carrier-free bifunctional nanoinhibitor was developed for HIPEC therapy in the management of peritoneal metastases. Self-assembly of the nanoinhibitor was formed by mixing Mn ion and epigallocatechin gallate (EGCG) in a controllable manner. Such nanoinhibitor directly inhibited HSP90 and impaired the HSP90 chaperone cycle by reduced intracellular\u00a0ATP level. Additionally, heat and Mn ion synergistically induced oxidative stress and expression of caspase 1, which activated GSDMD by proteolysis and caused pyroptosis in tumor cells, triggering immunogenic inflammatory cell death and induced maturation of dendritic cells through the release of tumor antigens. This strategy to inhibit heat resistance in HIPEC presented an unprecedented paradigm for converting \u201ccold\u201d tumors into \u201chot\u201d ones, thus significantly eradicating disseminated tumors located deep in the abdominal cavity and stimulating immune response in peritoneal metastases of a mouse model. Collectively, the nanoinhibitor effectively induced pyroptosis of colon tumor cells under heat conditions by inhibiting heat stress resistance and increasing oxidative stress, which may provide a new strategy for treatment of colorectal peritoneal metastases.<\/jats:p>","DOI":"10.1186\/s12943-023-01790-2","type":"journal-article","created":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T11:02:17Z","timestamp":1686740537000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Metal-enriched HSP90 nanoinhibitor overcomes heat resistance in hyperthermic intraperitoneal chemotherapy used for peritoneal metastases"],"prefix":"10.1186","volume":"22","author":[{"given":"Qiang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingfei","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin-bin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaojuan","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengxing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leli","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changhua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,14]]},"reference":[{"issue":"3","key":"1790_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"1790_CR2","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1245\/s10434-019-07526-1","volume":"27","author":"AC Gamboa","year":"2020","unstructured":"Gamboa AC, Zaidi MY, Lee RM, Speegle S, Switchenko JM, Lipscomb J, Cloyd JM, Ahmed A, Grotz T, Leiting J, Fournier K, Lee AJ, Dineen S, Powers BD, Lowy AM, Kotha NV, Clarke C, Gamblin TC, Patel SH, Lee TC, Lambert L, Hendrix RJ, Abbott DE, Vande Walle K, Lafaro K, Lee B, Johnston FM, Greer J, Russell MC, Staley CA, Maithel SK. Optimal Surveillance Frequency After CRS\/HIPEC for Appendiceal and Colorectal Neoplasms: A Multi-institutional Analysis of the US HIPEC Collaborative. Ann Surg Oncol. 2020;27(1):134\u201346.","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"1790_CR3","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/S2468-1253(19)30239-0","volume":"4","author":"CEL Klaver","year":"2019","unstructured":"Klaver CEL, Wisselink DD, Punt CJA, Snaebjornsson P, Crezee J, Aalbers AGJ, Brandt A, Bremers AJA, Burger JWA, Fabry HFJ, Ferenschild F, Festen S, van Grevenstein WMU, Hemmer PHJ, de Hingh IHJT, Kok NFM, Musters GD, Schoonderwoerd L, Tuynman JB, van de Ven AWH, van Westreenen HL, Wiezer MJ, Zimmerman DDE, van Zweeden AA, Dijkgraaf MGW, Tanis PJ, COLOPEC Collaborators Group. Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial. Lancet Gastroenterol Hepatol. 2019;4(10):761\u201370.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"2","key":"1790_CR4","doi-asserted-by":"publisher","first-page":"e41","DOI":"10.1016\/j.clcc.2015.12.006","volume":"15","author":"LG Razenberg","year":"2016","unstructured":"Razenberg LG, van Gestel YR, Lemmens VE, de Hingh IH, Creemers GJ. Bevacizumab in addition to palliative chemotherapy for patients with peritoneal carcinomatosis of colorectal origin: a nationwide population-based study. Clin Colorectal Cancer. 2016;15(2):e41-46.","journal-title":"Clin Colorectal Cancer"},{"issue":"3","key":"1790_CR5","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1200\/JCO.22.01690","volume":"41","author":"VK Morris","year":"2023","unstructured":"Morris VK, Kennedy EB, Baxter NN, Benson AB 3rd, Cercek A, Cho M, Ciombor KK, Cremolini C, Davis A, Deming DA, Fakih MG, Gholami S, Hong TS, Jaiyesimi I, Klute K, Lieu C, Sanoff H, Strickler JH, White S, Willis JA, Eng C. Treatment of metastatic colorectal cancer: ASCO Guideline. J Clin Oncol. 2023;41(3):678\u2013700.","journal-title":"J Clin Oncol"},{"issue":"2","key":"1790_CR6","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1093\/annonc\/mdf019","volume":"13","author":"D Elias","year":"2002","unstructured":"Elias D, Bonnay M, Puizillou JM, Antoun S, Demirdjian S, El OA, Pignon JP, Drouard-Troalen L, Ouellet JF, Ducreux M. Heated intra-operative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetics and tissue distribution. Ann Oncol. 2002;13(2):267\u201372.","journal-title":"Ann Oncol"},{"issue":"8","key":"1790_CR7","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1001\/jamaoncol.2021.0580","volume":"7","author":"RM Van Stein","year":"2021","unstructured":"Van Stein RM, Aalbers AGJ, Sonke GS, van Driel WJ. Hyperthermic intraperitoneal chemotherapy for ovarian and colorectal cancer: a review. JAMA Oncol. 2021;7(8):1231\u20138.","journal-title":"JAMA Oncol"},{"issue":"12","key":"1790_CR8","doi-asserted-by":"publisher","first-page":"2961","DOI":"10.1200\/JCO.1995.13.12.2961","volume":"13","author":"P Francis","year":"1995","unstructured":"Francis P, Rowinsky E, Schneider J, Hakes T, Hoskins W, Markman M. Phase I feasibility and pharmacologic study of weekly intraperitoneal paclitaxel: a Gynecologic Oncology Group pilot Study. J Clin Oncol. 1995;13(12):2961\u20137.","journal-title":"J Clin Oncol"},{"issue":"4","key":"1790_CR9","doi-asserted-by":"publisher","first-page":"203","DOI":"10.2165\/11598890-000000000-00000","volume":"51","author":"C Hasovits","year":"2012","unstructured":"Hasovits C, Clarke S. Pharmacokinetics and pharmacodynamics of intraperitoneal cancer chemotherapeutics. Clin Pharmacokinet. 2012;51(4):203\u201324.","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"1790_CR10","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1080\/02656736.2019.1631494","volume":"36","author":"A Sharma","year":"2019","unstructured":"Sharma A, \u00d6zayral S, Caserto JS, Ten Cate R, Anders NM, Barnett JD, Kandala SK, Henderson E, Stewart J, Liapi E, Rudek MA, Franken NAP, Oei AL, Korangath P, Bunz F, Ivkov R. Increased uptake of doxorubicin by cells undergoing heat stress does not explain its synergistic cytotoxicity with hyperthermia. Int J Hyperthermia. 2019;36(1):712\u201320.","journal-title":"Int J Hyperthermia"},{"issue":"2","key":"1790_CR11","first-page":"415","volume":"33","author":"RJ Palzer","year":"1973","unstructured":"Palzer RJ, Heidelberger C. Studies on the quantitative biology of hyperthermic killing of HeLa cells. Cancer Res. 1973;33(2):415\u201321.","journal-title":"Cancer Res"},{"issue":"1","key":"1790_CR12","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S1040-8428(01)00179-2","volume":"43","author":"B Hildebrandt","year":"2002","unstructured":"Hildebrandt B, Wust P, Ahlers O, Dieing A, Sreenivasa G, Kerner T, Felix R, Riess H. The cellular and molecular basis of hyperthermia. Crit Rev Oncol Hematol. 2002;43(1):33\u201356.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"4","key":"1790_CR13","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1245\/s10434-012-2784-6","volume":"20","author":"JO Pelz","year":"2013","unstructured":"Pelz JO, Vetterlein M, Grimmig T, Kerscher AG, Moll E, Lazariotou M, Matthes N, Faber M, Germer CT, Waaga-Gasser AM, Gasser M. Hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis: role of heat shock proteins and dissecting effects of hyperthermia. Ann Surg Oncol. 2013;20(4):1105\u201313.","journal-title":"Ann Surg Oncol"},{"issue":"14","key":"1790_CR14","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1056\/NEJMra050111","volume":"353","author":"AJ Macario","year":"2005","unstructured":"Macario AJ, Conway de Macario E. Sick chaperones, cellular stress, and disease. N Engl J Med. 2005;353(14):1489\u2013501.","journal-title":"N Engl J Med."},{"issue":"10","key":"1790_CR15","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/nrm3658","volume":"14","author":"H Saibil","year":"2013","unstructured":"Saibil H. Chaperone machines for protein folding, unfolding and disaggregation. Nat Rev Mol Cell Biol. 2013;14(10):630\u201342.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"8","key":"1790_CR16","doi-asserted-by":"publisher","first-page":"881","DOI":"10.2217\/bmm-2018-0155","volume":"12","author":"M Kasanga","year":"2018","unstructured":"Kasanga M, Liu L, Xue L, Song X. Plasma heat shock protein 90-alpha have an advantage in diagnosis of colorectal cancer at early stage. Biomark Med. 2018;12(8):881\u201390.","journal-title":"Biomark Med"},{"issue":"8","key":"1790_CR17","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/nrc2887","volume":"10","author":"J Trepel","year":"2010","unstructured":"Trepel J, Mollapour M, Giaccone G, Neckers L. Targeting the dynamic HSP90 complex in cancer. Nat Rev Cancer. 2010;10(8):537\u201349.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"1790_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/15748928113089990031","volume":"9","author":"K Sidera","year":"2014","unstructured":"Sidera K, Patsavoudi E. HSP90 inhibitors: current development and potential in cancer therapy. Recent Pat Anticancer Drug Discov. 2014;9(1):1\u201320.","journal-title":"Recent Pat Anticancer Drug Discov"},{"issue":"6","key":"1790_CR19","first-page":"9385","volume":"15","author":"Y Tu","year":"2018","unstructured":"Tu Y, Tian Y, Wu Y, Cui S. Clinical significance of heat shock proteins in gastric cancer following hyperthermia stress: Indications for hyperthermic intraperitoneal chemoperfusion therapy. Oncol Lett. 2018;15(6):9385\u201391.","journal-title":"Oncol Lett"},{"issue":"2","key":"1790_CR20","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.ygyno.2022.02.022","volume":"165","author":"LA Moukarzel","year":"2022","unstructured":"Moukarzel LA, Ferrando L, Dopeso H, Stylianou A, Basili T, Pareja F, Da Cruz PA, Zoppoli G, Abu-Rustum NR, Reis-Filho JS, Long Roche K, Tew WP, Chi DS, Sonoda Y, Zamarin D, Aghajanian C, O\u2019Cearbhaill RE, Zivanovic O, Weigelt B. Hyperthermic intraperitoneal chemotherapy (HIPEC) with carboplatin induces distinct transcriptomic changes in ovarian tumor and normal tissues. Gynecol Oncol. 2022;165(2):239\u201347.","journal-title":"Gynecol Oncol"},{"issue":"7","key":"1790_CR21","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/nrm2918","volume":"11","author":"M Taipale","year":"2010","unstructured":"Taipale M, Jarosz DF, Lindquist S. HSP90 at the hub of protein homeostasis: emerging mechanistic insights. Nat Rev Mol Cell Biol. 2010;11(7):515\u201328.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"1790_CR22","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/s12276-019-0360-x","volume":"52","author":"HK Park","year":"2020","unstructured":"Park HK, Yoon NG, Lee JE, Hu S, Yoon S, Kim SY, Hong JH, Nam D, Chae YC, Park JB, Kang BH. Unleashing the full potential of Hsp90 inhibitors as cancer therapeutics through simultaneous inactivation of Hsp90, Grp94, and TRAP1. Exp Mol Med. 2020;52(1):79\u201391.","journal-title":"Exp Mol Med"},{"issue":"6956","key":"1790_CR23","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nature01913","volume":"425","author":"A Kamal","year":"2003","unstructured":"Kamal A, Thao L, Sensintaffar J, Zhang L, Boehm MF, Fritz LC, Burrows FJ. A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors. Nature. 2003;425(6956):407\u201310.","journal-title":"Nature"},{"issue":"3","key":"1790_CR24","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1021\/acs.jmedchem.0c01700","volume":"64","author":"SJ Mishra","year":"2021","unstructured":"Mishra SJ, Liu W, Beebe K, Banerjee M, Kent CN, Munthali V, Koren J 3rd, Taylor JA 3rd, Neckers LM, Holzbeierlein J, Blagg BSJ. The Development of Hsp90\u03b2-Selective Inhibitors to Overcome Detriments Associated with pan-Hsp90 Inhibition. J Med Chem. 2021;64(3):1545\u201357.","journal-title":"J Med Chem"},{"issue":"7","key":"1790_CR25","doi-asserted-by":"publisher","first-page":"3239","DOI":"10.1158\/0008-5472.CAN-06-2968","volume":"67","author":"A Maloney","year":"2007","unstructured":"Maloney A, Clarke PA, Naaby-Hansen S, Stein R, Koopman JO, Akpan A, Yang A, Zvelebil M, Cramer R, Stimson L, Aherne W, Banerji U, Judson I, Sharp S, Powers M, deBilly E, Salmons J, Walton M, Burlingame A, Waterfield M, Workman P. Gene and protein expression profiling of human ovarian cancer cells treated with the heat shock protein 90 inhibitor 17-allylamino-17-demethoxygeldanamycin. Cancer Res. 2007;67(7):3239\u201353.","journal-title":"Cancer Res"},{"issue":"5","key":"1790_CR26","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1021\/acscentsci.2c00013","volume":"8","author":"S Bhatia","year":"2022","unstructured":"Bhatia S, Spanier L, Bickel D, Dienstbier N, Woloschin V, Vogt M, Pols H, Lungerich B, Reiners J, Aghaallaei N, Diedrich D, Frieg B, Schliehe-Diecks J, Bopp B, Lang F, Gopalswamy M, Loschwitz J, Bajohgli B, Skokowa J, Borkhardt A, Hauer J, Hansen FK, Smits SHJ, Jose J, Gohlke H, Kurz T. Development of a First-in-Class Small-Molecule Inhibitor of the C-Terminal Hsp90 Dimerization. ACS Cent Sci. 2022;8(5):636\u201355.","journal-title":"ACS Cent Sci"},{"issue":"1","key":"1790_CR27","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s12943-020-01283-6","volume":"19","author":"JM Park","year":"2020","unstructured":"Park JM, Kim YJ, Park S, Park M, Farrand L, Nguyen CT, Ann J, Nam G, Park HJ, Lee J, Kim JY, Seo JH. A novel HSP90 inhibitor targeting the C-terminal domain attenuates trastuzumab resistance in HER2-positive breast cancer. Mol Cancer. 2020;19(1):161.","journal-title":"Mol Cancer"},{"issue":"6","key":"1790_CR28","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/nrc2641","volume":"9","author":"CS Yang","year":"2009","unstructured":"Yang CS, Wang X, Lu G, Picinich SC. Cancer prevention by tea: animal studies, molecular mechanisms and human relevance. Nat Rev Cancer. 2009;9(6):429\u201339.","journal-title":"Nat Rev Cancer"},{"issue":"14","key":"1790_CR29","doi-asserted-by":"publisher","first-page":"3146","DOI":"10.3390\/molecules25143146","volume":"25","author":"SA Almatroodi","year":"2020","unstructured":"Almatroodi SA, Almatroudi A, Khan AA, Alhumaydhi FA, Alsahli MA, Rahmani AH. Potential Therapeutic Targets of Epigallocatechin Gallate (EGCG), the Most Abundant Catechin in Green Tea, and Its Role in the Therapy of Various Types of Cancer. Molecules. 2020;25(14):3146.","journal-title":"Molecules"},{"key":"1790_CR30","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.semcancer.2020.05.011","volume":"80","author":"V Aggarwal","year":"2022","unstructured":"Aggarwal V, Tuli HS, Tania M, Srivastava S, Ritzer EE, Pandey A, Aggarwal D, Barwal TS, Jain A, Kaur G, Sak K, Varol M, Bishayee A. Molecular mechanisms of action of epigallocatechin gallate in cancer: Recent trends and advancement. Semin Cancer Biol. 2022;80:256\u201375.","journal-title":"Semin Cancer Biol"},{"key":"1790_CR31","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1186\/1471-2407-10-276","volume":"10","author":"PL Tran","year":"2010","unstructured":"Tran PL, Kim SA, Choi HS, Yoon JH, Ahn SG. Epigallocatechin-3-gallate suppresses the expression of HSP70 and HSP90 and exhibits anti-tumor activity in vitro and in vivo. BMC Cancer. 2010;10:276.","journal-title":"BMC Cancer"},{"key":"1790_CR32","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1158\/1940-6207.CAPR-14-0224","volume":"8","author":"MA Moses","year":"2015","unstructured":"Moses MA, Henry EC, Ricke WA, Gasiewicz TA. The heat shock protein 90 inhibitor, (-)-epigallocatechin gallate, has anticancer activity in a novel human prostate cancer progression model. Cancer Prev Res. 2015;8:249\u201357.","journal-title":"Cancer Prev Res"},{"key":"1790_CR33","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/B978-0-12-385855-9.00007-2","volume":"53","author":"D Chen","year":"2011","unstructured":"Chen D, Wan SB, Yang H, Yuan J, Chan TH, Dou QP. EGCG, green tea polyphenols and their synthetic analogs and prodrugs for human cancer prevention and treatment. Adv Clin Chem. 2011;53:155\u201377.","journal-title":"Adv Clin Chem"},{"issue":"11","key":"1790_CR34","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/nnano.2014.208","volume":"9","author":"JE Chung","year":"2014","unstructured":"Chung JE, Tan S, Gao SJ, Yongvongsoontorn N, Kim SH, Lee JH, Choi HS, Yano H, Zhuo L, Kurisawa M, Ying JY. Self-assembled micellar nanocomplexes comprising green tea catechin derivatives and protein drugs for cancer therapy. Nat Nanotechnol. 2014;9(11):907\u201312.","journal-title":"Nat Nanotechnol"},{"key":"1790_CR35","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.biomaterials.2017.09.027","volume":"148","author":"KH Bae","year":"2017","unstructured":"Bae KH, Tan S, Yamashita A, Ang WX, Gao SJ, Wang S, Chung JE, Kurisawa M. Hyaluronic acid-green tea catechin micellar nanocomplexes: Fail-safe cisplatin nanomedicine for the treatment of ovarian cancer without off-target toxicity. Biomaterials. 2017;148:41\u201353.","journal-title":"Biomaterials"},{"issue":"14","key":"1790_CR36","doi-asserted-by":"publisher","first-page":"e1706963","DOI":"10.1002\/adma.201706963","volume":"30","author":"K Liang","year":"2018","unstructured":"Liang K, Chung JE, Gao SJ, Yongvongsoontorn N, Kurisawa M. Highly Augmented Drug Loading and Stability of Micellar Nanocomplexes Composed of Doxorubicin and Poly(ethylene glycol)-Green Tea Catechin Conjugate for Cancer Therapy. Adv Mater. 2018;30(14):e1706963.","journal-title":"Adv Mater"},{"issue":"2","key":"1790_CR37","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010;31(2):455\u201361.","journal-title":"J Comput Chem"},{"issue":"17","key":"1790_CR38","doi-asserted-by":"publisher","first-page":"3496","DOI":"10.1016\/j.molcel.2021.07.023","volume":"81","author":"K Lee","year":"2021","unstructured":"Lee K, Thwin AC, Nadel CM, Tse E, Gates SN, Gestwicki JE, Southworth DR. The structure of an Hsp90-immunophilin complex reveals cochaperone recognition of the client maturation state. Mol Cell. 2021;81(17):3496\u2013508.","journal-title":"Mol Cell"},{"issue":"5","key":"1790_CR39","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1002\/jcc.22885","volume":"33","author":"T Lu","year":"2012","unstructured":"Lu T, Chen F. Multiwfn: a multifunctional wavefunction analyzer. J Comput Chem. 2012;33(5):580\u201392.","journal-title":"J Comput Chem"},{"issue":"1","key":"1790_CR40","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/pro.3943","volume":"30","author":"EF Pettersen","year":"2021","unstructured":"Pettersen EF, Goddard TD, Huang CC, Meng EC, Couch GS, Croll TI, Morris JH, Ferrin TE. UCSF ChimeraX: Structure visualization for researchers, educators, and developers. Protein Sci. 2021;30(1):70\u201382.","journal-title":"Protein Sci"},{"key":"1790_CR41","unstructured":"Biovia DS. Discovery studio visualizer. San Diego, CA, USA 936; 2017. https:\/\/scholar.google.com\/scholar_lookup?title=Discovery+studio+visualizer&author=D.+S.+Biovia&publication_year=2017&."},{"issue":"1","key":"1790_CR42","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s12951-022-01300-4","volume":"20","author":"X Huang","year":"2022","unstructured":"Huang X, Qiu M, Wang T, Li B, Zhang S, Zhang T, Liu P, Wang Q, Qian ZR, Zhu C, Wu M, Zhao J. Carrier-free multifunctional nanomedicine for intraperitoneal disseminated ovarian cancer therapy. J Nanobiotechnol. 2022;20(1):93.","journal-title":"J Nanobiotechnol"},{"key":"1790_CR43","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.ijpharm.2019.04.053","volume":"564","author":"X Ke","year":"2019","unstructured":"Ke X, Tang H, Mao HQ. Effective encapsulation of curcumin in nanoparticles enabled by hydrogen bonding using flash nanocomplexation. Int J Pharm. 2019;564:273\u201380.","journal-title":"Int J Pharm"},{"key":"1790_CR44","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.mattod.2020.08.019","volume":"42","author":"H Hu","year":"2021","unstructured":"Hu H, Yang C, Li M, Shao D, Mao HQ, Leong KW. Flash Technology-Based Self-Assembly in Nanoformulation: From Fabrication to Biomedical Applications. Mater Today (Kidlington). 2021;42:99\u2013116.","journal-title":"Mater Today (Kidlington)"},{"key":"1790_CR45","doi-asserted-by":"publisher","first-page":"125301","DOI":"10.1016\/j.foodchem.2019.125301","volume":"301","author":"M Shi","year":"2019","unstructured":"Shi M, Ying DY, Hlaing MM, Ye JH, Sanguansri L, Augustin MA. Development of broccoli by-products as carriers for delivering EGCG. Food Chem. 2019;301:125301.","journal-title":"Food Chem"},{"key":"1790_CR46","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/s12665-019-8127-1","volume":"78","author":"D Wang","year":"2019","unstructured":"Wang D, Kim D, Shin CH, Zhao Y, Park JS, Ryu M. Evaluation of epigallocatechin gallate (EGCG) to remove Pb(II) using spectroscopic and quantum chemical calculation method. Environ Earth Sci. 2019;78:138.","journal-title":"Environ Earth Sci"},{"issue":"4","key":"1790_CR47","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1021\/mp900037p","volume":"6","author":"Y Li","year":"2009","unstructured":"Li Y, Zhang T, Jiang Y, Lee HF, Schwartz SJ, Sun D. (-)-Epigallocatechin-3-gallate inhibits Hsp90 function by impairing Hsp90 association with cochaperones in pancreatic cancer cell line Mia Paca-2. Mol Pharm. 2009;6(4):1152\u20139.","journal-title":"Mol Pharm"},{"issue":"2","key":"1790_CR48","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1021\/bi801637q","volume":"48","author":"Z Yin","year":"2009","unstructured":"Yin Z, Henry EC, Gasiewicz TA. (-)-Epigallocatechin-3-gallate is a novel Hsp90 inhibitor. Biochemistry. 2009;48(2):336\u201345.","journal-title":"Biochemistry"},{"issue":"6","key":"1790_CR49","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/nrm.2017.20","volume":"18","author":"FH Schopf","year":"2017","unstructured":"Schopf FH, Biebl MM, Buchner J. The HSP90 chaperone machinery. Nat Rev Mol Cell Biol. 2017;18(6):345\u201360.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1790_CR50","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.biomaterials.2018.12.004","volume":"194","author":"X Sun","year":"2019","unstructured":"Sun X, Zhang G, Du R, Xu R, Zhu D, Qian J, Bai G, Yang C, Zhang Z, Zhang X, Zou D, Wu Z. A biodegradable MnSiO3@Fe3O4 nanoplatform for dual-mode magnetic resonance imaging guided combinatorial cancer therapy. Biomaterials. 2019;194:151\u201360.","journal-title":"Biomaterials"},{"issue":"2","key":"1790_CR51","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.drup.2004.01.004","volume":"7","author":"H Pelicano","year":"2004","unstructured":"Pelicano H, Carney D, Huang P. ROS stress in cancer cells and therapeutic implications. Drug Resist Updat. 2004;7(2):97\u2013110.","journal-title":"Drug Resist Updat"},{"issue":"25","key":"1790_CR52","doi-asserted-by":"publisher","first-page":"11326","DOI":"10.1021\/jacs.2c03256","volume":"144","author":"L Yu","year":"2022","unstructured":"Yu L, Xu Y, Pu Z, Kang H, Li M, Sessler JL, Kim JS. Photocatalytic Superoxide Radical Generator that Induces Pyroptosis in Cancer Cells. J Am Chem Soc. 2022;144(25):11326\u201337.","journal-title":"J Am Chem Soc"},{"issue":"7575","key":"1790_CR53","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/nature15514","volume":"526","author":"J Shi","year":"2015","unstructured":"Shi J, Zhao Y, Wang K, Shi X, Wang Y, Huang H, Zhuang Y, Cai T, Wang F, Shao F. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature. 2015;526(7575):660\u20135.","journal-title":"Nature"},{"issue":"1","key":"1790_CR54","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/s13046-021-02065-8","volume":"40","author":"R Loveless","year":"2021","unstructured":"Loveless R, Bloomquist R, Teng Y. Pyroptosis at the forefront of anticancer immunity. J Exp Clin Cancer Res. 2021;40(1):264.","journal-title":"J Exp Clin Cancer Res"},{"issue":"18","key":"1790_CR55","doi-asserted-by":"publisher","first-page":"8813","DOI":"10.7150\/thno.62521","volume":"11","author":"SK Hsu","year":"2021","unstructured":"Hsu SK, Li CY, Lin IL, Syue WJ, Chen YF, Cheng KC, Teng YN, Lin YH, Yen CH, Chiu CC. Inflammation-related pyroptosis, a novel programmed cell death pathway, and its crosstalk with immune therapy in cancer treatment. Theranostics. 2021;11(18):8813\u201335.","journal-title":"Theranostics"},{"issue":"22","key":"1790_CR56","doi-asserted-by":"publisher","first-page":"4579","DOI":"10.1016\/j.molcel.2021.09.003","volume":"81","author":"J Hou","year":"2021","unstructured":"Hou J, Hsu JM, Hung MC. Molecular mechanisms and functions of pyroptosis in inflammation and antitumor immunity. Mol Cell. 2021;81(22):4579\u201390.","journal-title":"Mol Cell"},{"issue":"1","key":"1790_CR57","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1152\/physrev.00023.2001","volume":"82","author":"MF Lipscomb","year":"2002","unstructured":"Lipscomb MF, Masten BJ. Dendritic cells: immune regulators in health and disease. Physiol Rev. 2002;82(1):97\u2013130.","journal-title":"Physiol Rev"},{"issue":"1","key":"1790_CR58","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1097\/SLA.0b013e3182197102","volume":"254","author":"YL Klaver","year":"2011","unstructured":"Klaver YL, Hendriks T, Lomme RM, Rutten HJ, Bleichrodt RP, de Hingh IH. Hyperthermia and intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis: an experimental study. Ann Surg. 2011;254(1):125\u201330.","journal-title":"Ann Surg"},{"key":"1790_CR59","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1146\/annurev.biochem.75.103004.142738","volume":"75","author":"LH Pearl","year":"2006","unstructured":"Pearl LH, Prodromou C. Structure and mechanism of the Hsp90 molecular chaperone machinery. Annu Rev Biochem. 2006;75:271\u201394.","journal-title":"Annu Rev Biochem"},{"issue":"8","key":"1790_CR60","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/S1470-2045(02)00818-5","volume":"3","author":"P Wust","year":"2002","unstructured":"Wust P, Hildebrandt B, Sreenivasa G, Rau B, Gellermann J, Riess H, Felix R, Schlag PM. Hyperthermia in combined treatment of cancer. Lancet Oncol. 2002;3(8):487\u201397.","journal-title":"Lancet Oncol"},{"issue":"1","key":"1790_CR61","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1080\/02656730701769841","volume":"24","author":"JL Roti Roti","year":"2008","unstructured":"Roti Roti JL. Cellular responses to hyperthermia (40\u201346 degrees C): cell killing and molecular events. Int J Hyperthermia. 2008;24(1):3\u201315.","journal-title":"Int J Hyperthermia"},{"key":"1790_CR62","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/bs.acr.2015.10.001","volume":"129","author":"MW Graner","year":"2016","unstructured":"Graner MW. HSP90 and immune modulation in cancer. Adv Cancer Res. 2016;129:191\u2013224.","journal-title":"Adv Cancer Res"},{"issue":"4","key":"1790_CR63","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.immuni.2018.03.017","volume":"48","author":"C Wang","year":"2018","unstructured":"Wang C, Guan Y, Lv M, Zhang R, Guo Z, Wei X, Du X, Yang J, Li T, Wan Y, Su X, Huang X, Jiang Z. Manganese Increases the Sensitivity of the cGAS-STING Pathway for Double-Stranded DNA and Is Required for the Host Defense against DNA Viruses. Immunity. 2018;48(4):675\u201387.","journal-title":"Immunity"},{"issue":"11","key":"1790_CR64","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1038\/s41565-021-00962-9","volume":"16","author":"X Sun","year":"2021","unstructured":"Sun X, Zhang Y, Li J, Park KS, Han K, Zhou X, Xu Y, Nam J, Xu J, Shi X, Wei L, Lei YL, Moon JJ. Amplifying STING activation by cyclic dinucleotide-manganese particles for local and systemic cancer metalloimmunotherapy. Nat Nanotechnol. 2021;16(11):1260\u201370.","journal-title":"Nat Nanotechnol"},{"issue":"4","key":"1790_CR65","doi-asserted-by":"publisher","first-page":"e2004788","DOI":"10.1002\/adma.202004788","volume":"33","author":"M Chang","year":"2021","unstructured":"Chang M, Hou Z, Wang M, Li C, Lin J. Recent advances in hyperthermia therapy-based synergistic immunotherapy. Adv Mater. 2021;33(4):e2004788.","journal-title":"Adv Mater"},{"issue":"4","key":"1790_CR66","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41575-019-0255-2","volume":"17","author":"HCH Lau","year":"2020","unstructured":"Lau HCH, Kranenburg O, Xiao H, Yu J. Organoid models of gastrointestinal cancers in basic and translational research. Nat Rev Gastroenterol Hepatol. 2020;17(4):203\u201322.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1790_CR67","doi-asserted-by":"publisher","first-page":"117906441773055","DOI":"10.1177\/1179064417730559","volume":"10","author":"T Grimmig","year":"2017","unstructured":"Grimmig T, Moll EM, Kloos K, Thumm R, Moench R, Callies S, Kreckel J, Vetterlein M, Pelz J, Polat B, Tripathi S, Rehder R, Ribas CM, Chandraker A, Germer CT, Waaga-Gasser AM, Gasser M. Upregulated heat shock proteins after hyperthermic chemotherapy point to induced cell survival mechanisms in affected tumor cells from peritoneal carcinomatosis. Cancer Growth Metastasis. 2017;10:1179064417730559.","journal-title":"Cancer Growth Metastasis"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-023-01790-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12943-023-01790-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-023-01790-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T02:24:07Z","timestamp":1702607047000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecular-cancer.biomedcentral.com\/articles\/10.1186\/s12943-023-01790-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,14]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1790"],"URL":"https:\/\/doi.org\/10.1186\/s12943-023-01790-2","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,14]]},"assertion":[{"value":"31 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All patients provided informed consent, and all procedures followed the guidelines of Helsinki Declaration and ethical regulations approved by Medical Ethics Committee of the Seventh Affiliated Hospital, Sun Yat-sen University (KY-2022\u2013039-02). The animal experiments were in accordance with National Regulation of China for Care and Use of Laboratory Animals approved by Institution Animal Care and Use Committee, Sun Yat-Sen University (SYSU-IACUC-2022-B1716).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors give consent for the publication of the manuscript in Molecular Cancer.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"95"}}